Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ADTRAN Holdings Inc | QH9 | Apr 29, 2024 | 4.19 | -0.26 |
AIXTRON SE | AIXA | Apr 29, 2024 | 21.87 | -4.16 |
Atoss Software AG | AOF | Apr 29, 2024 | 260.00 | +1.56 |
Bechtle AG | BC8 | Apr 29, 2024 | 46.26 | -0.26 |
Cancom SE | COK | Apr 29, 2024 | 29.72 | +1.50 |
Carl Zeiss Meditec A G | AFX | Apr 29, 2024 | 100.70 | +0.40 |
Cdax-Gesamtindex (Perf) | CDAX | Apr 29, 2024 | 1 564.36 | -0.07 |
CompuGroup Medical SE & Co KgaA | COP | Apr 29, 2024 | 28.64 | +0.49 |
Dax (Performanceindex) | DAX | Apr 29, 2024 | 18 118.00 | -0.24 |
Deutsche Telekom AG | DTE | Apr 29, 2024 | 21.79 | -0.27 |
Energiekontor AG | EKT | Apr 29, 2024 | 64.10 | +1.10 |
Evotec SE | EVT | Apr 29, 2024 | 9.63 | +4.22 |
Freenet AG | FNTN | Apr 29, 2024 | 27.06 | -0.15 |
Hensoldt AG | HAG | Apr 29, 2024 | 37.90 | -0.99 |
Infineon Technologies AG | IFX | Apr 29, 2024 | 32.80 | -0.70 |
Jenoptik AG | JEN | Apr 29, 2024 | 25.40 | 0.00 |
Kontron AG. | KTN | Apr 29, 2024 | 19.40 | +1.68 |
Mdax (Performanceindex) | MDAX | Apr 29, 2024 | 26 345.00 | +0.65 |
Morphosys AG | MOR | Apr 29, 2024 | 65.65 | -3.24 |
Nagarro SE | NA9 | Apr 29, 2024 | 72.50 | +1.19 |
Nemetschek SE | NEM | Apr 29, 2024 | 82.45 | -0.42 |
Nordex SE | NDX1 | Apr 29, 2024 | 13.26 | +3.92 |
PNE AG | PNE3 | Apr 29, 2024 | 13.58 | +1.34 |
QIAGEN NV | QIA | Apr 29, 2024 | 39.15 | +0.99 |
Sap SE | SAP | Apr 29, 2024 | 171.42 | -1.48 |
Sartorius AG PRF PERPETUAL EUR | SRT3 | Apr 29, 2024 | 291.80 | +0.55 |
Sdax (Performance-Index) | SDXP | Apr 29, 2024 | 14 464.00 | +1.46 |
Siemens Healthineers AG | SHL | Apr 29, 2024 | 52.74 | -0.38 |
Siltronic AG | WAF | Apr 29, 2024 | 74.50 | -2.04 |
SMA Solar Technology AG | S92 | Apr 29, 2024 | 50.95 | +0.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.